top of page

The platform for the next generation of everyday testing

Bio-Stream is building the infrastructure for a future where many diagnostic tests can be developed, launched, funded, distributed, and used through a shared platform. 

 

The goal is simple: turn diagnostic science into practical test results that support better decisions when and where they happen. 

Bio-Stream’s trax™ platform combines sensor, reader, app, cloud, and commercialization support for building, launching, and scaling point-of-use testing.  

A connected system for point-of-use testing 

trax™ brings together the core components needed to support electrochemical diagnostic tests from development through deployment. 

01

trax™ sensor

Disposable test cartridges designed to support specific biomarker tests. 

IMG_0632 (2)_edited.jpg
IMG_0626 2_edited_edited.jpg

02

trax™ reader 

A portable reader that connects test results to the digital layer. 

03

biztrax™ 

The mobile app for people at work to execute market-ready business tests

IMG_0664_edited_edited.jpg
Business Portal login.png

04

Cloud Services 

Secure infrastructure for data handling, test support, and connected deployment. 

05

Commercialization Support 

The partner pathway for moving tests toward launch, distribution, and scale. 

IMG_0752 3_edited.jpg
ChatGPT Image Aug 12, 2026, 07_32_59 PM_edited_edited.png

One Platform. Many tests.

A new biomarker test should not need an entirely new device, software system, commercial pathway, and distribution model every time. 

trax™ is designed to support many tests through a shared platform, helping reduce fragmentation and making it easier for developers, partners, funders, and users to participate in point-of-use diagnostics. 

ChatGPT Image Aug 6, 2026, 03_28_45 PM_edited.jpg

Develop a Test

For researchers, universities, independent developers, and companies with a TRL 3 or TRL 6 biosensor.

ChatGPT Image Aug 6, 2026, 03_29_04 PM_edited.jpg

Commercialize a Test

For companies that want to launch, brand, distribute, or collect royalties from a biomarker-based test. 

ChatGPT Image Aug 6, 2026, 03_29_29 PM_edited_edited_edited_edited.png

Invest in a Test

For funders and investors interested in earning a return from the sale of specific test consumables. 

ChatGPT Image Aug 6, 2026, 02_31_53 PM_edited_edited_edited_edited.jpg

Use a Test

For people, providers, organizations, and end-users who want better  access to testing at the point of need)

Bring a test to life.

bottom of page